$TCBX
Third Coast Bancshares, Inc.

2023 Q2 Form 10-Q Financial Statement

#000095017023019778 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $897.0K $866.0K
YoY Change 409.66% 65.9%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $28.62M $24.55M
YoY Change 499.81% 1143.62%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $11.14M $11.49M
YoY Change 286.71% 326.27%
Income Tax $2.250M $2.200M
% Of Pretax Income 20.2% 19.15%
Net Earnings $7.707M $9.243M
YoY Change 238.47% 342.88%
Net Earnings / Revenue
Basic Earnings Per Share $0.57 $0.60
Diluted Earnings Per Share $0.46 $0.55
COMMON SHARES
Basic Shares Outstanding 13.58M 13.58M
Diluted Shares Outstanding 16.86M 16.80M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $244.8M $309.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $50.50M $28.50M
YoY Change 120.63% 36.74%
Goodwill $18.03M $18.03M
YoY Change 0.0%
Intangibles $1.050M $1.090M
YoY Change -12.94%
Long-Term Investments
YoY Change
Other Assets $7.808M $7.146M
YoY Change 8.76% 67.83%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.963B $3.860B
YoY Change 18.03% 26.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.522M $1.636M
YoY Change 109.27% 322.74%
Accrued Expenses $22.44M $19.85M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $25.96M $21.48M
YoY Change 1442.54% 5450.65%
LONG-TERM LIABILITIES
Long-Term Debt $111.3M $111.3M
YoY Change 0.08% 36.52%
Other Long-Term Liabilities $21.97M $17.33M
YoY Change -18.35% -13.9%
Total Long-Term Liabilities $133.3M $128.6M
YoY Change -3.51% 26.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.96M $21.48M
Total Long-Term Liabilities $133.3M $128.6M
Total Liabilities $3.568B $3.473B
YoY Change 16.74% 26.78%
SHAREHOLDERS EQUITY
Retained Earnings $65.89M $58.18M
YoY Change 52.64%
Common Stock $13.69M $13.66M
YoY Change -94.81%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.099M $1.099M
YoY Change 0.0%
Treasury Stock Shares $78.46K
Shareholders Equity $395.9M $387.0M
YoY Change
Total Liabilities & Shareholders Equity $3.963B $3.860B
YoY Change 18.03% 26.95%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $7.707M $9.243M
YoY Change 238.47% 342.88%
Depreciation, Depletion And Amortization $897.0K $866.0K
YoY Change 409.66% 65.9%
Cash From Operating Activities $10.50M $7.979M
YoY Change 152.53% 804.65%
INVESTING ACTIVITIES
Capital Expenditures $1.113M $709.0K
YoY Change -142.37% -69.49%
Acquisitions
YoY Change
Other Investing Activities -$136.9M -$113.5M
YoY Change -62.16% -76.4%
Cash From Investing Activities -$138.0M -$114.2M
YoY Change -62.12% -76.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 84.62M 85.19M
YoY Change -72.63% -83.83%
NET CHANGE
Cash From Operating Activities 10.50M 7.979M
Cash From Investing Activities -138.0M -114.2M
Cash From Financing Activities 84.62M 85.19M
Net Change In Cash -42.92M -21.07M
YoY Change -16.03% -147.57%
FREE CASH FLOW
Cash From Operating Activities $10.50M $7.979M
Capital Expenditures $1.113M $709.0K
Free Cash Flow $9.387M $7.270M
YoY Change 38.35% -604.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
100821000
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001781730
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41028
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
THIRD COAST BANCSHARES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2135597
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
20202 Highway 59 North
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 190
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Humble
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
709000
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77338
CY2023Q1 dei City Area Code
CityAreaCode
281
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
446-7000
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $1.00 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
TCBX
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13580355
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309153000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
329864000
CY2023Q1 us-gaap Federal Funds Sold
FederalFundsSold
1789000
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
2150000
CY2023Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
310942000
CY2022Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
332014000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
180376000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
176067000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
35915000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
30351000
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3177411000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
3077200000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
19026000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
18340000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28504000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28662000
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
64235000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
60761000
CY2023Q1 tcbx Non Marketable Equity Securities
NonMarketableEquitySecurities
14751000
CY2022Q4 tcbx Non Marketable Equity Securities
NonMarketableEquitySecurities
14618000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7146000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6303000
CY2023Q1 us-gaap Fair Value Hedge Assets At Fair Value
FairValueHedgeAssetsAtFairValue
8793000
CY2022Q4 us-gaap Fair Value Hedge Assets At Fair Value
FairValueHedgeAssetsAtFairValue
9213000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19328000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17872000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1090000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1131000
CY2023Q1 us-gaap Goodwill
Goodwill
18034000
CY2022Q4 us-gaap Goodwill
Goodwill
18034000
CY2023Q1 us-gaap Other Assets
OtherAssets
10021000
CY2022Q4 us-gaap Other Assets
OtherAssets
12933000
CY2023Q1 us-gaap Assets
Assets
3859657000
CY2022Q4 us-gaap Assets
Assets
3773148000
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
516909000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
486114000
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
2805624000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
2750032000
CY2023Q1 us-gaap Deposits
Deposits
3322533000
CY2022Q4 us-gaap Deposits
Deposits
3236146000
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1636000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2545000
CY2023Q1 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
7271000
CY2022Q4 us-gaap Fair Value Hedge Liabilities At Fair Value
FairValueHedgeLiabilitiesAtFairValue
9221000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19845000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
18209000
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
10054000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
14024000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
30875000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
30875000
CY2023Q1 us-gaap Junior Subordinated Notes
JuniorSubordinatedNotes
80399000
CY2022Q4 us-gaap Junior Subordinated Notes
JuniorSubordinatedNotes
80348000
CY2023Q1 us-gaap Liabilities
Liabilities
3472613000
CY2022Q4 us-gaap Liabilities
Liabilities
3391368000
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
69000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
69000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13657960
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13610198
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13579498
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13531736
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
13658000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
13610000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
318350000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
318033000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
58182000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
53270000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2116000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2103000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
78462
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
78462
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1099000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1099000
CY2023Q1 tcbx Stockholders Equity Attributable To Parent Excluding Esop Owned Shares
StockholdersEquityAttributableToParentExcludingEsopOwnedShares
387044000
CY2022Q4 tcbx Stockholders Equity Attributable To Parent Excluding Esop Owned Shares
StockholdersEquityAttributableToParentExcludingEsopOwnedShares
381780000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3859657000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3773148000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
53911000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
26682000
CY2023Q1 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
1548000
CY2022Q1 us-gaap Interest Income Debt Securities Available For Sale Operating
InterestIncomeDebtSecuritiesAvailableForSaleOperating
276000
CY2023Q1 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
1920000
CY2022Q1 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
226000
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
57379000
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
27184000
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
22092000
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1844000
CY2023Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
2457000
CY2022Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
130000
CY2023Q1 us-gaap Interest Expense
InterestExpense
24549000
CY2022Q1 us-gaap Interest Expense
InterestExpense
1974000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
32830000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25210000
CY2023Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1200000
CY2022Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
4000000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
31630000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
21210000
CY2023Q1 tcbx Noninterest Income Service Charges And Fees
NoninterestIncomeServiceChargesAndFees
779000
CY2022Q1 tcbx Noninterest Income Service Charges And Fees
NoninterestIncomeServiceChargesAndFees
619000
CY2023Q1 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
97000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
475000
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
143000
CY2023Q1 tcbx Noninterest Income Derivative Fees
NoninterestIncomeDerivativeFees
-1000
CY2022Q1 tcbx Noninterest Income Derivative Fees
NoninterestIncomeDerivativeFees
706000
CY2023Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
552000
CY2022Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
198000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
1902000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
1666000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13712000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13324000
CY2023Q1 tcbx Noninterest Expense Data Processing And Network Expense
NoninterestExpenseDataProcessingAndNetworkExpense
1203000
CY2022Q1 tcbx Noninterest Expense Data Processing And Network Expense
NoninterestExpenseDataProcessingAndNetworkExpense
922000
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
2633000
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
1873000
CY2023Q1 tcbx Noninterest Expense Legal And Professional Expense
NoninterestExpenseLegalAndProfessionalExpense
1930000
CY2022Q1 tcbx Noninterest Expense Legal And Professional Expense
NoninterestExpenseLegalAndProfessionalExpense
1746000
CY2023Q1 tcbx Loan Operations Expense Income
LoanOperationsExpenseIncome
-35000
CY2022Q1 tcbx Loan Operations Expense Income
LoanOperationsExpenseIncome
278000
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
686000
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
427000
CY2023Q1 us-gaap Communication
Communication
139000
CY2022Q1 us-gaap Communication
Communication
100000
CY2023Q1 tcbx Software Purchases And Maintenance
SoftwarePurchasesAndMaintenance
352000
CY2022Q1 tcbx Software Purchases And Maintenance
SoftwarePurchasesAndMaintenance
198000
CY2023Q1 tcbx Regulatory Assessments
RegulatoryAssessments
666000
CY2022Q1 tcbx Regulatory Assessments
RegulatoryAssessments
645000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
758000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
668000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
22044000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
20181000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11488000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2695000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2245000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
608000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9243000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2087000
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1171000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8072000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2087000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9243000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2087000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1439000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-590000
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-97000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-282000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-124000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1060000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-466000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
1531000
CY2023Q1 tcbx Reclassification Adjustment For Accretion Of Gain On Terminated Cash Flow Hedges Recorded In Interest Expense During The Period
ReclassificationAdjustmentForAccretionOfGainOnTerminatedCashFlowHedgesRecordedInInterestExpenseDuringThePeriod
206000
CY2022Q1 tcbx Reclassification Adjustment For Accretion Of Gain On Terminated Cash Flow Hedges Recorded In Interest Expense During The Period
ReclassificationAdjustmentForAccretionOfGainOnTerminatedCashFlowHedgesRecordedInInterestExpenseDuringThePeriod
51000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
278000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-11000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1047000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-40000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-506000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9230000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1581000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
299007000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2087000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
279000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000
CY2022Q1 tcbx Common Stock Issued During Period Value Esop
CommonStockIssuedDuringPeriodValueESOP
282000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-506000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
301203000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
381780000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9243000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
365000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000
CY2023Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
16.88
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
387044000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
9243000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2087000
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1200000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
4000000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
365000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
279000
CY2023Q1 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
97000
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-133000
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-8000
CY2023Q1 tcbx Accretion Of Gain On Terminated Cash Flow Hedges
AccretionOfGainOnTerminatedCashFlowHedges
206000
CY2022Q1 tcbx Accretion Of Gain On Terminated Cash Flow Hedges
AccretionOfGainOnTerminatedCashFlowHedges
51000
CY2023Q1 tcbx Accretion Of Sba Paycheck Protection Program Fees
AccretionOfSbaPaycheckProtectionProgramFees
13000
CY2022Q1 tcbx Accretion Of Sba Paycheck Protection Program Fees
AccretionOfSbaPaycheckProtectionProgramFees
1350000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
51000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
222000
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-388000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
475000
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
143000
CY2023Q1 tcbx Net Change In Operating Leases
NetChangeInOperatingLeases
180000
CY2022Q1 tcbx Net Change In Operating Leases
NetChangeInOperatingLeases
-67000
CY2023Q1 tcbx Net Change In Fair Value Hedge Assets And Liabilities
NetChangeInFairValueHedgeAssetsAndLiabilities
1000
CY2022Q1 tcbx Net Change In Fair Value Hedge Assets And Liabilities
NetChangeInFairValueHedgeAssetsAndLiabilities
8000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2228000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3658000
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-4853000
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-7159000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7979000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
882000
CY2023Q1 tcbx Proceeds From Payments For Federal Home Loan Bank And Federal Reserve Bank Stock
ProceedsFromPaymentsForFederalHomeLoanBankAndFederalReserveBankStock
-133000
CY2022Q1 tcbx Proceeds From Payments For Federal Home Loan Bank And Federal Reserve Bank Stock
ProceedsFromPaymentsForFederalHomeLoanBankAndFederalReserveBankStock
-3800000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
10117000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
101082000
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
3880000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
551000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
698000
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
104713000
CY2022Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
376993000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
99428000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2324000
CY2022Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
10000
CY2023Q1 us-gaap Payments For Proceeds From Life Insurance Policies
PaymentsForProceedsFromLifeInsurancePolicies
3000000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-114241000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-483491000
CY2023Q1 tcbx Payments For Proceeds From Deposit
PaymentsForProceedsFromDeposit
-86387000
CY2022Q1 tcbx Payments For Proceeds From Deposit
PaymentsForProceedsFromDeposit
-446060000
CY2022Q1 us-gaap Proceeds From Issuance Of Subordinated Long Term Debt
ProceedsFromIssuanceOfSubordinatedLongTermDebt
80507000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
55000
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1197000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
85190000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
526904000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21072000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
44295000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
332014000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
327025000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
310942000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
371320000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
25458000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
2023000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1907000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10890000
CY2023Q1 tcbx Number Of Branch Offices
NumberOfBranchOffices
16
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
58908000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
54146000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
5062000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
4574000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
164791000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
158148000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
22978000
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
686000
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
427000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
22228000
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reclassification</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain amounts in prior period consolidated financial statements may have been reclassified to conform to current period presentation. These reclassifications are immaterial and have no effect on net income, total assets or shareholders’ equity.</span></p>
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
30351000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
187769000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7393000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
180376000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
182118000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
297000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6348000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
176067000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
187769000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
180376000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
4302000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3091000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
7393000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
180376000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6348000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
6348000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
167724000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
38
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
35
CY2023Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2023Q1 tcbx Number Of Securities Pledged As Collateral
NumberOfSecuritiesPledgedAsCollateral
0
CY2022Q4 tcbx Number Of Securities Pledged As Collateral
NumberOfSecuritiesPledgedAsCollateral
0
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3213326000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3107551000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
35915000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
30351000
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
3177411000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3077200000
CY2023Q1 tcbx Loans And Leases Receivable Unaccreted Discounts And Deferred Fees Net Of Deferred Costs
LoansAndLeasesReceivableUnaccretedDiscountsAndDeferredFeesNetOfDeferredCosts
9400000
CY2022 tcbx Loans And Leases Receivable Unaccreted Discounts And Deferred Fees Net Of Deferred Costs
LoansAndLeasesReceivableUnaccretedDiscountsAndDeferredFeesNetOfDeferredCosts
7800000
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
9482000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
10963000
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
518000
CY2023Q1 tcbx Financing Receivable Accrued Income For Nonaccrual Loans
FinancingReceivableAccruedIncomeForNonaccrualLoans
339000
CY2022Q1 tcbx Financing Receivable Accrued Income For Nonaccrual Loans
FinancingReceivableAccruedIncomeForNonaccrualLoans
482000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3213326000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3107551000
CY2023Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
0
CY2023Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
19708000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
15502000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
4213000
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
19715000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1600000
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
18659000
CY2022Q1 tcbx Loans And Leases Receivable Interest Income Received On Impaired Loans
LoansAndLeasesReceivableInterestIncomeReceivedOnImpairedLoans
120000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
3213326000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3107551000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
35915000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
30351000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
858670
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1200000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
141000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
505000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
35915000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
19295000
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
4000000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
17000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23312000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1801000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
34114000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
35915000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1600000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
28751000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
30351000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39859000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39151000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11355000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10489000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28504000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28662000
CY2023Q1 us-gaap Depreciation
Depreciation
866000
CY2022Q1 us-gaap Depreciation
Depreciation
522000
CY2023Q1 us-gaap Noninterest Bearing Domestic Deposit Demand
NoninterestBearingDomesticDepositDemand
516909000
CY2022Q4 us-gaap Noninterest Bearing Domestic Deposit Demand
NoninterestBearingDomesticDepositDemand
486114000
CY2023Q1 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
2530348000
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
2498325000
CY2023Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
36202000
CY2022Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
35677000
CY2023Q1 tcbx Deposits Excluding Time Deposits
DepositsExcludingTimeDeposits
3083459000
CY2022Q4 tcbx Deposits Excluding Time Deposits
DepositsExcludingTimeDeposits
3020116000
CY2023Q1 us-gaap Time Deposits
TimeDeposits
239074000
CY2022Q4 us-gaap Time Deposits
TimeDeposits
216030000
CY2023Q1 us-gaap Deposits
Deposits
3322533000
CY2022Q4 us-gaap Deposits
Deposits
3236146000
CY2023Q1 tcbx Time Deposits250000 Or More
TimeDeposits250000OrMore
151200000
CY2022Q4 tcbx Time Deposits250000 Or More
TimeDeposits250000OrMore
135500000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.15
CY2023Q1 us-gaap Time Deposit Maturities Remainder Of Fiscal Year
TimeDepositMaturitiesRemainderOfFiscalYear
140028000
CY2023Q1 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
87753000
CY2023Q1 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
8313000
CY2023Q1 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
1678000
CY2023Q1 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
935000
CY2023Q1 tcbx Time Deposit Maturities Year Five And Thereafter
TimeDepositMaturitiesYearFiveAndThereafter
367000
CY2023Q1 us-gaap Time Deposits
TimeDeposits
239074000
CY2023Q1 us-gaap Deposit Liabilities Reclassified As Loans Receivable1
DepositLiabilitiesReclassifiedAsLoansReceivable1
85000
CY2022Q4 us-gaap Deposit Liabilities Reclassified As Loans Receivable1
DepositLiabilitiesReclassifiedAsLoansReceivable1
31000
CY2023Q1 tcbx Deposit Liabilities Related Parties
DepositLiabilitiesRelatedParties
17000000.0
CY2022Q4 tcbx Deposit Liabilities Related Parties
DepositLiabilitiesRelatedParties
16000000.0
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2200000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
608000
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.195
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.226
CY2023Q1 tcbx Borrowing Capacity Available Under Federal Home Loan Bank Stock And Real Estate Loans
BorrowingCapacityAvailableUnderFederalHomeLoanBankStockAndRealEstateLoans
745000000.0
CY2022Q4 tcbx Borrowing Capacity Available Under Federal Home Loan Bank Stock And Real Estate Loans
BorrowingCapacityAvailableUnderFederalHomeLoanBankStockAndRealEstateLoans
719100000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
0
CY2023Q1 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
0
CY2023Q1 tcbx Letters Of Credit Amount Issued
LettersOfCreditAmountIssued
294500000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
676270
CY2023Q1 tcbx Line Of Credit Maturity Year One
LineOfCreditMaturityYearOne
30875000
CY2023Q1 tcbx Junior Subordinated Notes Maturities Summary Due In Year Five And Thereafter
JuniorSubordinatedNotesMaturitiesSummaryDueInYearFiveAndThereafter
80399000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
30875000
CY2023Q1 us-gaap Junior Subordinated Notes
JuniorSubordinatedNotes
80399000
CY2023Q1 tcbx Maximum Borrowing Capacity Under Federal Fund Line Of Credit
MaximumBorrowingCapacityUnderFederalFundLineOfCredit
36500000
CY2022Q4 tcbx Maximum Borrowing Capacity Under Federal Fund Line Of Credit
MaximumBorrowingCapacityUnderFederalFundLineOfCredit
36500000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
109908
CY2020Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
97821
CY2020Q1 tcbx Share Based Compensation Arrangement By Share Based Payment Award Exchange Ratio
ShareBasedCompensationArrangementByShareBasedPaymentAwardExchangeRatio
0.89
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0342
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0414
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.1781
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.1789
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y6M
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0145
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0417
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.1000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.3800
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y6M
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
142000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
118000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1800000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
798000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
798000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2100000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1800000
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
24000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.82
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.95
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
136000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.80
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
65080
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.59
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
219900
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3.07
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
44400
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
3.46
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
98500
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
3.70
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
579790
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.81
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
676270
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.82
CY2023Q1 tcbx Fair Value Of Warrants Included In Additional Paid In Capital
FairValueOfWarrantsIncludedInAdditionalPaidInCapital
380000
CY2023Q1 tcbx Weighted Average Remaining Contractual Life Of Stock Warrants Outstanding
WeightedAverageRemainingContractualLifeOfStockWarrantsOutstanding
P6Y6M
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19300000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19800000
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0424
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y4M20D
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
982000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
600000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
62000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
191000
CY2023Q1 us-gaap Lease Cost
LeaseCost
1044000
CY2022Q1 us-gaap Lease Cost
LeaseCost
791000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000.0
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
791000
CY2023Q1 tcbx Foreclosed Asset
ForeclosedAsset
0
CY2022Q4 tcbx Foreclosed Asset
ForeclosedAsset
0
CY2023Q1 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
404431000
CY2023Q1 us-gaap Capital
Capital
486350000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1985000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3043000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3079000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3152000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3214000
CY2023Q1 tcbx Lessee Operating Lease Liability Payments Due In Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueInFiveAndThereafter
13973000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
28446000
CY2023Q1 tcbx Lessee Operating Lease Liability In Discount On Cash Flows
LesseeOperatingLeaseLiabilityInDiscountOnCashFlows
-4256000
CY2023Q1 tcbx Lessee Operating Lease Liability In Lease Signed But Not Yet Commenced
LesseeOperatingLeaseLiabilityInLeaseSignedButNotYetCommenced
-4345000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
19845000
CY2023Q1 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
1258922000
CY2022Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
1169740000
CY2023Q1 tcbx Off Balance Sheet Credit Loss Liability Allowance For Credit Loss
OffBalanceSheetCreditLossLiabilityAllowanceForCreditLoss
0
CY2023Q1 tcbx Fair Value Assets Transfers Between Levels12 And3 Amount
FairValueAssetsTransfersBetweenLevels12And3Amount
0
CY2022Q4 tcbx Fair Value Assets Transfers Between Levels12 And3 Amount
FairValueAssetsTransfersBetweenLevels12And3Amount
0
CY2023Q1 tcbx Fair Value Liabilities Transfers Between Levels12 And3 Amount
FairValueLiabilitiesTransfersBetweenLevels12And3Amount
0
CY2022Q4 tcbx Fair Value Liabilities Transfers Between Levels12 And3 Amount
FairValueLiabilitiesTransfersBetweenLevels12And3Amount
0
CY2023Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
18400000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
1800000
CY2023Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
16600000
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
19700000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
1600000
CY2022Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
18100000
CY2023Q1 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.126
CY2023Q1 us-gaap Federal Funds Sold
FederalFundsSold
1800000
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
2100000
CY2023Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
179600000
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
279100000
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
400000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q3 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
149461
CY2023Q1 tcbx Employee Stock Ownership Plan Esop Share Value Of Contributions To Esop
EmployeeStockOwnershipPlanEsopShareValueOfContributionsToEsop
332000
CY2022Q1 tcbx Employee Stock Ownership Plan Esop Share Value Of Contributions To Esop
EmployeeStockOwnershipPlanEsopShareValueOfContributionsToEsop
330000
CY2023Q1 tcbx Employee Stock Ownership Plan Esop Administrative Expense
EmployeeStockOwnershipPlanEsopAdministrativeExpense
25000
CY2022Q1 tcbx Employee Stock Ownership Plan Esop Administrative Expense
EmployeeStockOwnershipPlanEsopAdministrativeExpense
10000
CY2023Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1000000.0
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1500000
CY2023Q1 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
123000
CY2023Q1 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
581000
CY2023Q1 tcbx Related Party Unfunded Commitments
RelatedPartyUnfundedCommitments
839000
CY2022Q4 tcbx Related Party Unfunded Commitments
RelatedPartyUnfundedCommitments
587000
CY2023Q1 tcbx Deposit Liabilities Related Parties
DepositLiabilitiesRelatedParties
17000000.0
CY2022Q4 tcbx Deposit Liabilities Related Parties
DepositLiabilitiesRelatedParties
16000000.0
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q1 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.105
CY2023Q1 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
370036000
CY2023Q1 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.096
CY2023Q1 tcbx Tier One Risk Based Capital Required For Capital Adequacy With Buffer
TierOneRiskBasedCapitalRequiredForCapitalAdequacyWithBuffer
327396000
CY2023Q1 tcbx Tier One Risk Based Capital Required For Capital Adequacy With Buffer To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyWithBufferToRiskWeightedAssets
0.085
CY2023Q1 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
370036000
CY2023Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.101
CY2023Q1 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
146022000
CY2023Q1 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.040
CY2023Q1 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
303811000
CY2023Q1 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.079
CY2023Q1 us-gaap Common Equity Tier One Capital Required For Capital Adequacy
CommonEquityTierOneCapitalRequiredForCapitalAdequacy
269620000
CY2023Q1 us-gaap Banking Regulation Common Equity Tier One Risk Based Capital Ratio Capital Adequacy Minimum
BankingRegulationCommonEquityTierOneRiskBasedCapitalRatioCapitalAdequacyMinimum
0.070
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
9243000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2087000
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1171000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8072000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2087000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13532545
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13385324
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3269270
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
369702
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16801815
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13755026
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q1 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
525409000
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
8793000
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
7271000
CY2022Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
335101000
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
9213000
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
9221000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40000

Files In Submission

Name View Source Status
0000950170-23-019778-index-headers.html Edgar Link pending
0000950170-23-019778-index.html Edgar Link pending
0000950170-23-019778.txt Edgar Link pending
0000950170-23-019778-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tcbx-20230331.htm Edgar Link pending
tcbx-20230331.xsd Edgar Link pending
tcbx-ex31_1.htm Edgar Link pending
tcbx-ex31_2.htm Edgar Link pending
tcbx-ex32_1.htm Edgar Link pending
tcbx-ex32_2.htm Edgar Link pending
tcbx-20230331_cal.xml Edgar Link unprocessable
tcbx-20230331_def.xml Edgar Link unprocessable
tcbx-20230331_lab.xml Edgar Link unprocessable
tcbx-20230331_pre.xml Edgar Link unprocessable
tcbx-20230331_htm.xml Edgar Link completed